Details
August 13 (5:00PM) - 19 (9:00PM), 2020
National Broadcast to Announce the Approval of a Second Indication for TAZVERIK™ (tazemetostat)
Hosted by Epizyme
WEBINAR - Multiple Broadcast Times
Learn more about a new treatment option for your relapsed or refractory follicular lymphoma (FL) patients
In this Live Broadcast, Dr. Pagel, Dr. Burke, and Dr. Kurtin will:
- Review the Prescribing Information for this new treatment available for relapsed or refractory FL patients
- Present clinical safety and efficacy data in this patient population
- Provide important dosing and patient counseling information
- Discuss a hypothetical patient case study
Add to Calendar
aCLuDhaqizCaPxAftmqF167204
08/13/2020 05:00 PM
08/19/2020 09:00 PM
false
National Broadcast to Announce the Approval of a Second Indication for TAZVERIK™ (tazemetostat)
Learn more about a new treatment option for your relapsed or refractory follicular lymphoma (FL) patients
In this Live Broadcast, Dr. Pagel, Dr. Burke, and Dr. Kurtin will:
Review the Prescribing Information for this new treatment available for relapsed or refractory FL patients
Present clinical safety and efficacy data in this patient population
Provide important dosing and patient counseling information
Discuss a hypothetical patient case study
Click here to register
View the flier
WEBINAR - Multiple Broadcast Times
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!
